15 Set-It-and-Forget-It Stocks to Buy According to Analysts

Page 10 of 15

6. Pfizer Inc. (NYSE:PFE)

Analyst Upside: 17.32%

Number of Hedge Fund Holders: 99

Pfizer Inc. (NYSE:PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared that the Phase 3 BASIS research results showed that its medication HYMPAVZI (marstacimab) was superior to other inhibitors in treating hemophilia A or B patients.

Comparing HYMPAVZI to on-demand treatment, the trial revealed that the former decreased the annualized bleeding rate by 93%. A pre-filled pen was used to administer HYMPAVZI once weekly via subcutaneous injection, requiring little preparation. During the study, no thromboembolic events or deaths were reported, indicating that the medication was generally well tolerated.

Pfizer Inc. (NYSE:PFE) intends to present the data to regulatory bodies in order to start the regulatory filing process for HYMPAVZI in hemophilia patients with inhibitors. The medication has already been approved by regulators in the United States and Europe for use in hemophilia patients without inhibitors.

Pfizer Inc. (NYSE:PFE) is a leading global pharmaceutical company that develops, produces, and sells biopharmaceutical medicines worldwide.

Page 10 of 15